NCT02873962 2026-04-01A Phase II Study Of Nivolumab/ Bevacizumab/RucaparibDana-Farber Cancer InstitutePhase 2 Active not recruiting72 enrolled 16 charts
NCT03337087 2024-05-17Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary CancerAcademic and Community Cancer Research UnitedPhase 1/2 Active not recruiting18 enrolled 12 charts